zika
viru
zikv
emerg
arthropodborn
viru
belong
genu
flaviviru
flavivirida
famili
intern
comitte
taxonomi
virus
ictv
viru
primarili
transmit
bite
aed
mosquito
zanluca
duart
do
santo
unlik
flavivirus
howev
persontoperson
zikv
transmiss
possibl
although
contribut
transmiss
mode
maintain
epidem
unclear
transmiss
sexual
perinat
interact
blood
platelet
transfus
describ
mlakar
et
al
noronha
et
al
miner
diamond
gener
zikv
infect
human
character
selflimit
diseas
frequent
sign
symptom
low
fever
myalgia
rash
arthralgia
headach
conjunctiv
hyperemia
duffi
et
al
zanluca
et
al
nevertheless
case
neurolog
manifest
syndrom
beckham
et
al
noronha
et
al
schulerfaccini
et
al
report
patient
diagnos
zikv
addit
zikv
infect
pregnanc
associ
fetal
malform
brain
microcalcif
central
nervou
system
disord
ocular
abnorm
arthrogryposi
part
congenit
zika
syndrom
brasil
et
al
melo
et
al
schulerfaccini
et
al
march
thirtyon
countri
territori
america
report
central
nervou
system
malform
potenti
associ
zikv
infect
brazil
affect
countri
date
world
health
organ
sinc
june
receiv
sampl
serum
urin
bodi
fluid
zikv
diagnosi
addit
peak
zikv
outbreak
brazil
agreement
local
health
author
pregnant
women
state
suspect
zikv
infect
monitor
sampl
tissu
placenta
umbil
cord
well
fetal
tissu
case
stillbirth
collect
time
deliveri
sent
laboratori
analysi
present
case
seri
analyz
placent
tissu
women
infect
zikv
differ
pregnanc
stage
focus
anatomopatholog
morphometr
find
target
cell
viral
persist
studi
approv
fiocruz
brazilian
nation
ethic
committe
human
experiment
number
caae
sinc
laboratori
refer
center
diagnosi
emerg
virus
brazilian
ministri
health
obtain
waiver
written
inform
consent
work
sampl
complianc
ethic
principl
studi
approv
abovement
ethic
committe
zikv
outbreak
brazil
pregnant
women
exhibit
zikv
infectioncompat
symptom
present
public
health
unit
state
two
hundr
ninetytwo
test
neg
zikv
infect
case
laboratoryconfirm
zikv
rtpcr
posit
case
two
patient
spontan
abort
remain
women
monitor
pregnanc
time
deliveri
report
describ
anatomopatholog
morphometr
find
placent
tissu
pregnant
women
confirm
zikv
infect
ie
posit
result
rtqpcr
immunohistochem
ihc
analysi
placent
tissu
although
zikv
infect
occur
differ
gestat
period
fragment
one
placent
tissu
analyz
studi
collect
immedi
deliveri
frozen
presenc
zikv
genom
sampl
investig
rtqpcr
appropri
presenc
antibodi
serum
sampl
screen
elisa
describ
addit
fragment
placenta
kept
buffer
formalin
anatomopatholog
morphometr
ihc
analys
clinic
condit
newborn
evalu
immedi
deliveri
followup
perform
viral
rna
isol
biolog
fluid
serum
cerebrospin
fluid
lacrim
fluid
saliva
urin
use
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
accord
manufactur
protocol
rna
extract
unfix
placenta
viscera
perform
rneasi
mini
kit
qiagen
rna
formalinfix
paraffinembed
ffpe
tissu
extract
use
ffpe
total
rna
miniprep
system
promega
madison
usa
rna
store
use
primer
probe
synthes
purifi
integr
dna
technolog
idt
coralvil
usa
report
dye
use
probe
realtim
assay
perform
gotaq
probe
rtqpcr
system
promega
amplif
lightcycl
instrument
roch
mannheim
germani
zikv
genom
detect
accord
protocol
lanciotti
et
al
lanciotti
et
al
use
rna
per
reaction
dengu
viru
denv
serotyp
detect
accord
protocol
johnson
et
al
johnson
et
al
human
rnase
p
use
endogen
control
emeri
et
al
posit
control
zikv
denv
obtain
viru
isol
brazilian
patient
sera
vero
cell
antizikv
igm
serum
sampl
detect
inhous
igm
captur
enzymelink
immunosorb
assay
macelisa
use
zikv
mock
noninfect
cell
cell
cultur
antigen
accord
center
diseas
control
prevent
center
diseas
control
prevent
cdc
guidelin
minor
modif
human
antiflaviviru
monoclon
antibodi
mab
kindli
provid
cdc
use
posit
control
serum
sampl
also
test
antidenv
antibodi
use
either
panbio
dengu
igm
captur
elisa
panbio
dengu
igg
indirect
elisa
aler
brisban
australia
follow
manufactur
instruct
placenta
fix
buffer
formalin
immedi
deliveri
umbil
cord
membran
disk
examin
multipl
parallel
section
taken
disk
interv
histolog
sampl
placent
villou
tissu
made
separ
area
distinct
cotyledon
least
three
section
taken
parenchyma
way
chorion
basal
plate
includ
also
section
cord
jelli
roll
membran
examin
deparaffin
rehydr
ffpe
placent
sampl
perform
use
xylen
ethanol
bath
respect
hydrogen
peroxidemethanol
use
block
endogen
peroxidas
activ
section
incub
antiflaviviru
specif
antizikv
produc
iccfiocruzpr
mab
rabbit
antimous
secondari
antibodi
follow
goat
antirabbit
antibodi
conjug
hrp
spring
bioscienc
pleasanton
usa
final
slide
incub
freshli
prepar
substrat
mixtur
dab
dakocytom
counterstain
mayer
hematoxylin
antizikv
mab
show
cross
reactiv
flavivirus
dengu
serotyp
yellow
fever
saint
loui
enceph
west
nile
virus
cell
cultur
model
supplementari
figur
addit
placent
sampl
etiolog
test
ihc
use
antizikv
mab
cross
reactiv
observ
also
rtqpcr
yield
neg
result
sampl
neg
control
obtain
either
omit
primari
antibodi
incub
step
use
unrel
mab
chikungunya
viru
chikv
produc
iccfiocruzpr
primari
antibodi
supplementari
figur
better
identifi
hofbauer
cell
hc
ffpe
placent
tissu
specimen
incub
primari
antibodi
antihuman
invitrogen
carlsbad
usa
use
protocol
placenta
slide
three
slide
placent
disc
one
slide
chorioamniot
membran
one
slide
umbil
cord
observ
optic
microscop
tokyo
japan
photomicrograph
acquir
highpow
field
use
zeiss
axio
scanner
carl
zeiss
thornwood
usa
routin
hematoxylineosin
h
e
stain
ihc
stain
villu
matur
evalu
consid
villu
morpholog
gestat
age
deliveri
morphometr
analys
perform
placent
tissu
specimen
mother
infect
zikv
first
n
second
n
third
trimest
pregnanc
n
neg
control
group
n
use
comparison
baurakiad
et
al
case
highpow
field
hpf
randomli
select
knot
sprout
field
count
mean
valu
paramet
field
use
statist
analys
zikainfect
uninfect
control
group
compar
use
oneway
anova
follow
dunnett
multipl
comparison
test
similarli
villi
hc
cell
count
field
placent
sampl
mother
infect
third
trimest
pregnanc
n
neg
control
group
n
zikainfect
uninfect
control
group
compar
use
mann
whitney
test
statist
analys
perform
use
graphpad
prism
softwar
differ
consid
statist
signific
p
report
describ
evalu
case
zikv
infect
confirm
pregnant
women
differ
gestat
period
tabl
serolog
analysi
perform
case
serum
sampl
avail
nine
case
present
antizikv
igm
antidenv
igg
one
antidenv
igg
presenc
igg
antibodi
suggest
past
flaviviru
infect
none
antizikv
igmposit
sampl
cross
react
antidenv
igm
elisa
tabl
case
neither
zikv
rna
antizikv
igm
detect
sampl
amniot
fluid
newborn
cerebrospin
fluid
csf
ocularor
swab
case
describ
articl
five
newborn
serum
sampl
avail
one
present
antizikv
igm
indic
transplacent
infect
although
congenit
disord
observ
time
deliveri
case
tabl
case
anatomopatholog
find
ffpe
placent
tissu
specimen
compil
tabl
note
although
panel
includ
sampl
women
zikv
infect
differ
stage
pregnanc
placent
sampl
obtain
time
deliveri
except
one
spontan
abort
week
gestat
first
trimest
placenta
case
addit
inform
case
publish
noronha
et
al
zikvposit
first
trimest
human
placent
sampl
exhibit
chronic
villiti
torchlik
featur
shown
tabl
figur
eight
third
trimest
human
placent
tissu
sampl
exhibit
patholog
featur
routin
h
estain
section
wherea
placenta
without
patholog
sign
observ
remain
case
preval
alter
delay
villou
matur
addit
stromal
chang
hyperplasia
hc
shown
tabl
figur
c
e
nine
case
exhibit
patholog
sign
h
e
stain
five
associ
congenit
disord
one
evolv
spontan
abort
first
trimest
placenta
case
remain
case
patholog
evid
observ
h
e
section
three
case
present
congenit
disord
tabl
six
case
villou
immatur
four
congenit
disord
diagnos
birth
two
intrauterin
fetal
death
tabl
one
acut
funis
one
umbil
arteri
agenesi
tabl
morphometr
analysi
placenta
women
infect
third
trimest
pregnanc
confirm
villou
immatur
hyperplasia
hc
figur
syncyti
knot
sprout
quantifi
demonstr
disord
villu
matur
higher
number
sprout
detect
zikvinfect
group
control
group
p
regardless
gestat
period
infect
figur
villi
hc
measur
evalu
hyperplasia
hc
compar
placenta
control
group
placenta
women
infect
zikv
third
trimest
show
increas
number
hc
hyperplasia
figur
immunohistochem
ihc
analysi
placent
tissu
sampl
use
antiflaviviru
mab
antizikv
mab
show
immunostain
hc
regardless
gestat
age
zikv
infect
occur
figur
f
cytotrophoblast
ctb
syncytiotrophoblast
stb
cell
chorion
frondosum
well
fibroblast
cell
wharton
jelli
neg
specimen
figur
f
umbil
cord
fibroblast
wharton
jelli
amniot
epithelium
chorioamniot
membran
capsular
decidua
amniot
epithelium
smooth
chorion
capsular
decidua
decidua
basali
sampl
consist
neg
antizikv
antiflaviviru
monoclon
antibodi
figur
intervil
space
show
matern
inflammatori
cell
infiltr
posit
antiflaviviru
antizikv
mab
first
trimest
placent
sampl
villiti
figur
zikv
infect
sampl
confirm
rtqpcr
use
rna
extract
ffpe
tissu
core
correspond
villiti
area
noronha
et
al
studi
examin
human
placent
sampl
natur
infect
women
focus
anatomopatholog
morpholog
aspect
sampl
determin
cell
target
zikv
pregnanc
main
histolog
find
h
e
section
placent
tissu
women
infect
zikv
differ
gestat
period
villou
immatur
stromal
chang
hyperplasia
hc
stromal
fibrosi
edema
stromal
villi
sclerot
villi
calcif
foci
fibrinoid
deposit
tabl
although
studi
natur
infect
placent
tissu
limit
two
previou
report
corrobor
find
martin
et
al
ritter
et
al
report
detect
chorion
villi
calcif
fibrosi
perivil
fibrin
deposit
patchi
intervillos
focal
villiti
case
present
patholog
sign
convers
tissu
sever
zikvposit
sampl
normalappear
chorion
villi
agreement
result
shown
tabl
martin
et
al
ritter
et
al
morphometr
analysi
show
enhanc
number
hc
syncyti
sprout
indic
villou
matur
disord
placenta
women
infect
zikv
late
gestat
period
compar
number
featur
control
group
placenta
syncyti
knot
special
syncytiotrophoblast
increas
structur
late
gestat
indic
placent
patholog
use
evalu
villou
matur
syncyti
sprout
marker
trophoblast
prolifer
seen
frequent
earli
pregnanc
increas
mani
diseas
loukeri
et
al
find
agre
result
studi
show
damag
effect
type
interferon
inf
ex
vivo
human
midgest
placent
tissu
treat
author
demonstr
type
inf
trigger
fetal
death
mous
model
treatment
ex
vivo
human
placenta
induc
morpholog
chang
villi
syncyti
knot
sprout
yockey
et
al
immunohistochem
analysi
reveal
hc
zikvposit
fetal
cell
natur
infect
human
placent
sampl
examin
studi
regardless
gestat
period
infect
occur
hc
remain
persist
infect
time
deliveri
noteworthi
even
tissu
sampl
women
infect
late
pregnanc
ie
short
interv
acut
phase
infect
deliveri
time
zikv
detect
exclus
hc
tabl
hc
placent
villou
macrophag
fetal
origin
alter
number
hyperplasia
biolog
featur
associ
complic
pregnanc
hc
play
role
divers
function
placent
vasculogenesi
immun
regul
secret
enzym
cytokin
across
maternalfet
barrier
addit
result
doublelabel
assay
show
associ
sprouti
protein
implic
villu
branch
morphogenesi
hc
suggest
involv
hc
develop
placent
villi
antebi
et
al
hc
categor
placent
macrophag
locat
migratori
behavior
confer
abil
move
around
villou
stroma
make
transient
contact
macrophag
villou
core
cell
khan
et
al
tang
et
al
anoth
fact
worth
mention
appar
correl
villou
immatur
congenit
disord
caus
zikv
infect
sinc
observ
occurr
fetal
malform
four
six
case
villou
immatur
observ
h
e
stain
morphometr
analysi
furthermor
villou
immatur
may
relat
increas
hc
cell
sustain
presenc
zikv
placenta
data
could
valuabl
pathologist
neonatologist
follow
newborn
expos
zikv
vertic
transmiss
note
case
first
trimest
placenta
villiti
exhibit
zikvposit
matern
inflammatori
cell
intervil
space
although
posit
fetal
endothelium
matern
leukocyt
ritter
et
al
decidu
cell
ctb
mesenchym
cell
chorion
villi
rabelo
et
al
first
trimest
placenta
also
report
specul
matern
fetal
cell
may
infect
transient
support
hypothesi
studi
natur
zikv
infect
use
either
ihc
situ
hybrid
analysi
ish
also
report
hc
frequent
observ
infect
cell
martin
et
al
noronha
et
al
bhatnagar
et
al
rosenberg
et
al
persist
zikvposit
fetal
hc
fullterm
placenta
regardless
period
infect
occur
indic
zikv
persist
placenta
sever
month
matern
infect
may
provid
viral
sourc
continu
fetal
infect
examin
entir
human
placenta
compris
umbil
cord
amniot
membran
chorion
frondosum
ctb
stb
smooth
chorion
capsular
decidua
decidua
basali
reveal
tissu
consist
neg
zikv
infect
mlakar
et
al
mlakar
et
al
report
similar
find
singl
case
rabelo
et
al
rabelo
et
al
show
zikv
protein
decidu
endotheli
cell
matern
decidua
ctb
stb
hc
third
trimest
placent
tissu
associ
hivexpos
uninfect
infant
sever
congenit
zika
syndrom
nonetheless
matern
hiv
infect
could
contribut
permiss
maternalplacent
cell
type
zikv
infect
thu
suggest
plausibl
hypothesi
transplacent
transmiss
zikv
would
relat
associ
hc
migratori
abil
reach
fetal
vessel
infect
fetu
either
transcytosi
zikvinfect
trojan
hors
cell
zanluca
et
al
furthermor
zikv
genom
materi
viral
particl
detect
placent
cell
end
pregnanc
regardless
trimest
infect
occur
plausibl
specul
infect
fetu
could
happen
secondari
event
ie
necessarili
concomit
matern
acut
phase
diseas
aagaard
et
al
case
understand
biolog
hc
zikv
infect
utmost
import
explain
differ
congenit
outcom
relat
zikv
infect
simoni
et
al
emphas
neg
zikv
detect
rtpcr
ihc
placent
sampl
exclud
possibl
matern
zikv
infect
possibl
reason
fals
neg
result
includ
zikv
rnaprotein
level
limit
detect
employ
assay
rna
degrad
due
storageship
process
variabl
tissu
sampl
viral
strain
exampl
eight
pregnant
women
describ
tabl
zikv
infect
confirm
rtqpcr
serum
sampl
acut
phase
infect
viral
rnaprotein
detect
placent
tissu
convers
studi
zikv
also
detect
placent
sampl
nine
women
onset
zikv
clinic
symptom
first
second
third
trimest
gave
birth
normal
infant
abnorm
infant
may
prevent
placent
integr
limit
viral
spread
mother
fetu
howev
exclud
fetal
exposur
zikv
noteworthi
case
abnorm
detect
month
deliveri
aragao
et
al
ventura
et
al
serolog
examin
clinic
followup
newborn
requir
confirm
defin
diagnosi
period
monitor
infant
may
help
earli
recognit
futur
sequela
congenit
infect
bhatnagar
et
al
conclus
tissu
analysi
provid
opportun
confirm
maternalplacent
zikv
infect
may
alert
practition
potenti
congenit
disord
child
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
